Ovarian Cancer Screening and AI
Starting soon · Not applicable
Conditions studied: Ovarian Cancer Screening Recommendations by Gynecologists
In brief
Gynecologists frequently overestimate the benefits and safety of ovarian cancer screening. AI-supported discussions may help correct these misperceptions. This study tests whether an AI-guided conversation about the evidence on ovarian cancer screening can improve gynecologists' knowledge and reduce non-evidence-based screening recommendations, compared with a control AI discussion on ovarian cancer prevalence.
Key facts
- Study ID
- NCT07503054
- Run by
- Charite University, Berlin, Germany
- People needed
- 350
- Starts
- 2026-03-27
- Expected to finish
- 2026-04-30
- Last updated by the study team
- 2026-03-31
Who can join
Age: 24 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- gynecologists in outpatient care who provide ovarian cancer screening to asymptomatic, average-risk women (not guideline consistent)
You may not qualify if…
- gynecologists in inpatient care
- gynecologist in outpatient care who do NOT provide ovarian cancer screening to asymptomatic, average-risk women (guideline consistent)
Where it is running
- Charité - Universitätsmedizin Berlin — Mitte, State of Berlin, Germany
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.